References
- Wang E, Law B, Stephens D. Pediatric Investigators Collaborative Network of Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. Pediatrics 1996; 129: 390–5.
- Fransén H, Sterner G, Forsgren M, et al. Acute lower respiratory illness in elderly patients with respiratory syncytial virus infection. Acta Med Scand 1967; 182: 323.
- Randolph AG, Wang EEL. Ribavirin for respiratory syncytial virus infection of the lower respiratory tract, Cochrane Library 2000; 2.
- The Impact-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 1998; 102: 531–7.
- Lindroth M. Skall vi aldrig säga nej? Till exempel till RSV-profylax. Läkartidningen 2000; 97: 208–9.
- Joffe S, Ray GT, Escobar GJ, Black SB, Lieu TA. Cost-effectiveness of respiratory syncytial virus prophylaxis among preterm infants. Pediatrics 1999; 104: 419–27.
- Hall CB. Respiratory syncytial virus: a continuing culprit and conundrun. J Pediatr 1999; 135: S2–7.
- Bennet R, Eriksson M. RS-virusinfektion vanligaste enskilda orsaken till sjukhusvård hos barn. Profylax vid hög risk ön-skvärd men lokal epidemiologi bör avgöra. Läkartidningen 2000; 97: 1123–6.
- Reyes M, Eriksson M, Bennet R, Hedlund K-O, Ehrnst A. Regular pattern of respiratory syncytial virus and rotavirus infections and relation to weather in Stockholm, 1984–1994. Clin Microbiol Infect 6; 1997: 640–6.
- Centers for Disease Control. Respiratory syncytial virus—Missouri. MMWR Morb Mortal Wkly Rep 1977; 26: 351.
- Simoes EAF. Respiratory syncytial virus infection. Lancet 1999; 354: 847–52.
- MacDonald NE, Hall CB, Suffin SC, Alexson C, Harris PJ, Manning JA. Respiratory syncytial virus infection in infants with congenital heart disease. N Engl J Med 1982; 307: 397–400.
- Carbonell-Estrany X, Quero J, Bustos G, Cotero A, Domenech E, Figueras-Aloy J, Fraga JM, Garcia LG, Garcia-Alix A, Del Rio MG, Kraul X, Sastre JB, Narbona E, Roques V, Hernandez SS, Zapatero M. Rehospitalization because of respiratory syncytial virus infection in premature infants younger than 33 weeks of gestation: a prospective study. Pediatr Infect Dis J 2000; 19 : 592–7.
- Simoes E. Respiratory syncytial virus and subsequent lower respiratory tract infections in developing countries: a new twist to an old virus. J Pediatr 1999; 135: 657–61.
- Ottolini MG, Hemming VG. Prevention and treatment recommendations for respiratory syncytial virus infection. Background and clinical experience 40 years after discovery. Drugs 1999; 54: 867.
- Mlinaric-Galinovic G, Falsey AR, Walsh EE. Respiratory syncytial virus infection in the elderly. Eur J Clin Microbiol Infect Dis 1996; 15: 777.
- Englund JA. Prevention strategies for respiratory syncytial virus: passive and active immunization. J Pediatr 1999; 135: S38–44.
- The PREVENT Study Group. Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. Pediatrics 1997; 99: 93–9.
- Randolph AG, Wang EE. Ribavirin for respiratory syncytial virus lower respiratory tract infection: a systematic overview. Arch Pediatr Adolesc Med 1996; 150: 942–7.
- Smith DW, Frankel LR, Mathers LH, Tang AT, Ariagno RL, Prober CG. A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection. N Engl J Med 1991; 325: 24–9.
- Whimbey E, Champlin RE, Couch RB, Englund JA, Goodrich JM, Raad I, Przepiorka D, Lewis VA, Mirzja N, Yousuf H, Tarrand JJ, Bodey GP. Community respiratory virus infections among hospitalized adult bone marrow transplant recipients. Clin Infect Dis 1996; 22: 778–82.
- DeVincenzo JP, Hirsch RL, Fuentes RJ, Top FH. Respiratory syncytial virus immune globulin treatment of lower respiratory tract infection in pediatric patients undergoing bone marrow transplantation—a compassionate use experience. Bone Marrow Transplant 2000; 25: 161–5.
- Lewinsohn D, Bowden R, Matsson D, Crawford S. Phase I study of intravenous ribavirin treatment of respiratory syncytial virus pneumonia after marrow transplantation. Antimicrob Agents Chemother 1996; 40: 2555–7.
- Sparrelid E, Ljungman P, Ekelof-Andstrom E, Aschan J, Ringden O, Winiarski J, Wahlin B, Andersson. Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections. Bone Marrow Transplant 1997; 19: 905–8.